Probiotics supplementation in the management of hepatocellular carcinoma

Affiliations

¹ Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.
² Liver Research Unit Medica Sur Clinic & Foundation and Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

Editorial

Ludovico Abenavoli et al. Hepatobiliary Surg Nutr. 2019 Dec.

. 2019 Dec;8(6):632-634.

doi: 10.21037/hbsn.2019.10.12.

¹ Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.
² Liver Research Unit Medica Sur Clinic & Foundation and Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.
Wan MLY, El-Nezami H. Wan MLY, et al. Hepatobiliary Surg Nutr. 2018 Feb;7(1):11-20. doi: 10.21037/hbsn.2017.12.07. Hepatobiliary Surg Nutr. 2018. PMID: 29531939 Free PMC article. Review.

1. Anstee QM, Reeves HL, Kotsiliti E, et al. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol 2019;16:411-28. 10.1038/s41575-019-0145-7 - DOI - PubMed
1. Nakagawa H, Maeda S. Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol 2012;18:4071-81. 10.3748/wjg.v18.i31.4071 - DOI - PMC - PubMed
1. Preveden T, Scarpellini E, Milić N, et al. Gut microbiota changes and chronic hepatitis C virus infection. Expert Rev Gastroenterol Hepatol 2017;11:813-19. 10.1080/17474124.2017.1343663 - DOI - PubMed
1. Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med 2016;375:2369-79. 10.1056/NEJMra1600266 - DOI - PubMed
1. Yu LX, Yan HX, Liu Q, et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 2010;52:1322-33. 10.1002/hep.23845 - DOI - PubMed